DelveInsight's 'Adenosine Antagonists Pipeline Insight 2024' report provides comprehensive global coverage of pipeline adenosine antagonists in various stages of clinical development, major ...
Tsukuba, Japan—The nucleus accumbens plays a pivotal role in motivational behavior and sleep regulation, modulated by adenosine A 2A receptors (A 2A R). Hence, selective A 2A R regulation within this ...
The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine receptors as potential drug targets in a range of brain disorders, including ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ADENOSINE VIATRIS contains the active ingredient adenosine. ADENOSINE ...
Although Merck & Co. Inc. continues to chalk up investor-pleasing sales with Keytruda (pembrolizumab) and Bristol-Myers Squibb Co. (BMS) keeps doing well with Opdivo (nivolumab), researchers have yet ...
Adenosine Therapeutics, a Charlottesville, Va., biotech developing drugs that target forms of a cell-surface protein called the adenosine receptor, is raising $14 million in a third funding round. The ...
Coupling will accelerate the clinical development of A2B antagonists. Novartis acquired an option to Adenosine Therapeutics’ (ATL) A2B receptor antagonist program. Adenosine Therapeutics will continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results